Mirae Asset Venture Investment
Investor profile
Mirae Asset Venture Investment has backed 4 European tech companies across 4 funding rounds between 2015 and 2022, joining rounds totalling €174M. Most active in Healthtech and E-commerce. Data as of Nov 2026.
Also recorded as: Mirae Asset Capital
Deals
4
distinct rounds
Companies
4
backed
Active span
2015–2022
8 yrs
Total round €
€174M
sum of rounds joined
Deals by year
distinct rounds / yearMirae Asset Venture Investment — deals by year — interactive chart.
Data table
| Mirae Asset Venture Investment — deals by year | |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2022 | 1 |
Top sectors
by dealsMirae Asset Venture Investment — top sectors — interactive chart.
Data table
| Mirae Asset Venture Investment — top sectors | |
|---|---|
| Healthtech | 3 |
| E-commerce | 1 |
| Fintech | 1 |
Stages
by dealsMirae Asset Venture Investment — stages — interactive chart.
Data table
| Mirae Asset Venture Investment — stages | |
|---|---|
| Other | 1 |
| Growth/Late | 1 |
| Series A | 1 |
| Series D+ | 1 |
Countries
by dealsMirae Asset Venture Investment — countries — interactive chart.
Data table
| Mirae Asset Venture Investment — countries | |
|---|---|
| Israel | 2 |
| Belgium | 1 |
| Germany | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Grover | Germany | 1 | €101M |
| Promethera Biosciences | Belgium | 1 | €40M |
| BiomX | Israel | 1 | €22M |
| KAHR Medical | Israel | 1 | €11M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Grover | Other | €101M | 2022-04 |
| Promethera Biosciences | Series D+ | €40M | 2019-04 |
| BiomX | Series A | €22M | 2017-05 |
| KAHR Medical | Growth/Late | €11M | 2015-12 |